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expression of genes that control cell growth and inhibit tumor formation. Analysis of mice that express
mutant forms of p53 suggest that inappropriate p53 activation can alter tissue homeostasis and life span,
connecting p53 tumor suppressor functions with accelerated aging. However, other mouse models that
display increased levels of wildtype p53 in various tissues fail to corroborate a link between p53 and aging
phenotypes, possibly due to the retention of signaling pathways that negatively regulate p53 activity in these
models. In this present study, we have generated mice lacking Mdm2 in the epidermis. Deletion of Mdm2, the
chief negative regulator of p53, induced an aging phenotype in the skin of mice, including thinning of the
epidermis, reduced wound healing, and a progressive loss of fur. These phenotypes arise due to an induction
of p53-mediated senescence in epidermal stem cells and a gradual loss of epidermal stem cell function. These
results reveal that activation of endogenous p53 by ablation of Mdm2 can induce accelerated aging
phenotypes in mice.cester, MA 01655, USA. Fax: +1
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The p53 transcription factor activates the expression of numerous
genes involved in cell cycling, senescence, and apoptosis (Vousden and
Lu, 2002). These p53 effectors regulate the growth of cells exposed to
certain types of DNA damage or metabolic insult, and mutation of p53 or
other genes encoding regulators of the p53 signaling pathway are the
most commongenetic alterations observed inhuman cancers (Soussi and
Beroud, 2001). In keeping with a key role for p53 in tumor suppression,
mice either heterozygous or homozygous-deﬁcient for functional p53
develop tumors either spontaneously (Donehower et al., 1992) or
following exposure to various genotoxic agents (Kemp et al., 1994).
The oncoprotein Mdm2 is a well-established negative regulator of
p53 activity. Mdm2 complexes with the amino-terminal portion of
p53 and interferes with the ability of p53 to transactivate target genes
by sterically hindering the NH2-terminal activation domain of the p53
protein (Momand et al., 1992; Chen et al., 1995) and by shuttling p53
from the nucleus to the cytoplasm (Freedman and Levine, 1998; Geyer
et al., 2000). Furthermore, Mdm2 can function as an E3 ligase to
ubiquitinate p53 (Honda et al., 1997) and induce p53 degradation in
the 26S proteasome (Haupt et al., 1997; Kubbutat et al., 1997; Li et al.,
2003). Studies of Mdm2-mutant mice have highlighted the funda-mental importance of Mdm2 in inhibiting p53 stability and function in
development (Jones et al., 1995; Montes de Oca Luna et al., 1995;
Itahana et al., 2007).
Recently, analysis of several p53 mouse models has suggested that
p53 must also be negatively regulated in adult mice in order to
facilitate homeostatic regulation of normal tissues and to prevent
accelerated organismal aging. We have reported previously that mice
heterozygous for a mutated p53 allele (m allele) encoding an amino-
truncated p53 display a reduced incidence of cancer relative to p53
heterozygous mice and an early aging-like phenotype that includes
osteoporosis, a reduced mass of internal organs, a thinning of the
dermis, and deﬁciencies in hair re-growth (Tyner et al., 2002). Since
expression of the m-allele was found to increase the transcriptional
activity of wildtype p53 molecules in vitro, it was proposed that the
m-allele bearing (p53 +/m) mice had a slight increase in the level of
p53 activity that reduced stem cell proliferation in the affected tissues,
leading to the loss of tissue cellularity and an accelerated aging-like
phenotype in this model (Tyner et al., 2002). More recently, the
Scrable lab performed an analysis of transgenic mice expressing a
short, naturally occurring, p53 splice isoform lacking sequences
encoding the amino terminal portion of the p53 protein. The variant
p53 protein (p44) encoded by this transgene induced p53 hyperac-
tivity in the transgenic mice and a reduced cancer incidence. In
agreementwith a role for p53 activity in aging, the p44mice displayed
an increase in aging-associated insulin growth factor signaling and
accelerated aging (Maier et al., 2004).
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increased amounts of p53 activity fail to present with accelerated
aging-like phenotypes. The “super-p53” transgenic mice harbor extra
copies of a wildtype p53 gene and display upregulated p53 activities
and increased cancer resistance; yet these mice have normal life span
and normal skeletal structure, hair growth, and skin thickness
(Garcia-Cao et al., 2002). Likewise, mice bearing reduced levels of
Mdm2 activity due to the presence of a hypomorphic Mdm2 allele
(Mdm2puro) were found to have increased levels of p53 activity and
increased resistance to tumor formation but did not possess any of the
features characteristic of accelerated aging (Mendrysa et al., 2006).
One possible explanation for the differences in the aging phenotypes
in these various mouse models is that the p53 proteins encoded by the
m-allele and the p44 transgene lack the amino-terminal portion of p53
containing the p53–Mdm2 interaction domain. Therefore, these variant
p53 proteins would not be subjected to Mdm2 regulation, whereas
Mdm2would negatively regulate thewildtype, full-length p53 proteins
encoded in the super p53 transgenic mice. And although there is
reduced Mdm2 function and increased p53 activity in the Mdm2-
hypomorphicmodel, the endogenouswildtype p53 proteins encoded in
these mice are still subject to Mdm2 binding and regulation, albeit at a
reduced level. Thus, it is possible that the ability (or inability) of Mdm2
to fully regulate p53 may underlie the presence or absence of any
accelerated aging phenotypes in these various mouse models. An
alternate explanation for the difference in aging-associated phenotypes
in thesemodels is that the amino-truncated formsof p53encodedby the
m-allele or the p44 transgene might be inducing an early aging
phenotype not only by altering p53 activity per se but also by altering
the activity of p63, a p53 family member that has been recently
demonstrated to regulate senescence inﬁbroblasts andepithelial cells in
a p53-independent manner (Guo et al., 2009; Flores and Blasco, 2009)
and to induce premature aging phenotypes in the skin of mice (Flores
and Blasco, 2009). Therefore, the role of p53 in regulating accelerated
aging inmice remains amatter of much debate (Poyurovsky and Prives,
2006; Vijg and Hasty, 2005; Gentry and Venkatachalam, 2005).
In this present study, we have utilized an Mdm2-conditional mouse
model to determine whether epidermal-speciﬁc loss of Mdm2–p53
signaling in newborn mice can induce a premature aging phenotype in
the skin. Such an approach allows us to avoid the embryonic lethality
associatedwithubiquitous or tissue-speciﬁc inactivation ofMdm2during
development (Jones et al., 1995;Montes de Oca Luna et al., 1995; Itahana
et al., 2007; Lengner et al., 2006; Xiong et al., 2006). Furthermore, in
contrast to p53, the stability and transcriptional activity of thep63protein
is not regulatedbyMdm2(Wanget al., 2001; Little and Jochemsen, 2001).
Therefore, ablationofMdm2permits a speciﬁcassessmentof theeffectsof
the endogenous p53 protein in organismal aging.
Our results reveal that deletion of Mdm2 activity in mouse skin
epithelium results in increased p53 levels and increased expression of
p53 target genes that are speciﬁcally involved in regulating cellular
senescence. These Mdm2-ablated mice display hallmarks of acceler-
ated aging in their skin, including a thinning of the epidermal layer,
reduced integrity of the skin, and widespread and progressive loss of
fur. Analysis of the epidermis in these mice indicates increased
cellular senescence in the follicular bulge region and a reduction in
skin epidermal stem cell numbers and functions, as determined by
wound healing and hair growth assays. These ﬁndings document a
role for Mdm2–p53 signaling in the maintenance of the epidermal
stem cell compartment and demonstrate that increased activity of
endogenous p53 can induce early aging phenotypes in mouse skin.
Materials and methods
Mice and mouse genotyping
The generation of both the Mdm2 conditional mice (Steinman and
Jones, 2002) and theK5-Cre transgenicmice (Zhou et al., 2002) has beendescribed previously. Rosa26 Flox-Stop-β-Geo reporter mice (Stock#:
003310)were obtained from Jackson Laboratories. All experimental and
littermate control mice used in this study were on a mixed 129Sv×
C57Bl/6 background. Genomic PCR was used to identify inheritance of
the K5-Cre transgene (primers 5′-CGGTCGATGCAACGAGTGAT-3′ and
5′-CCACCGTCAGTACGTGAGAT-3′), to identify inheritance of the condi-
tional Mdm2 allele (primers 5′-GGTCTTCCCATTTATGTATGT-3′ and 5′-
AAGAGTCTGTATCGCTTTCT-3′), and to verify Mdm2 allelic excision
(primers 5′-GGTCTTCCCATTTATGTATGT-3′ and 5′-TCCACCTCTTT-
CTTCTTCCTG-3′). Animals were maintained and used in accordance
with federal guidelines and those established by the Institutional
Animal Care and Use Committee at the University of Massachusetts
Medical School.
Western analysis
Protein lysates were collected using a modiﬁed protocol described
previously (Balasubramanian et al., 1998). A 10-mm2 dorsal section of
skin tissue was homogenized in 1 ml NP-40 lysis buffer [50 mM Tris–
HCl, pH 7.5; 150 mM NaCl; 0.5% NP-40; 20% Glycerol; 1× protease
inhibitor cocktail (Roche); 1× phosphatase inhibitor cocktail
(Roche)]. Samples were placed on ice for 15 minutes, vortexed, and
centrifuged at 13,000 rpm for 20 minutes. Supernatants were collect-
ed, and 50 μg of each sample loaded onto a 10% SDS–polyacrylamide
gel. Antibodies against p53 (1:500 of both Ab-1 and Ab-3 from
Calbiochem) and α-tubulin (1:4000 T5168 from Sigma) were diluted
in 5% non-fat milk.
Gene expression analysis
Total mRNA from skin tissue was isolated according to the Trizol
Reagent (Invitrogen) protocol and cDNA was generated using the
SuperScript II First Strand Synthesis Kit (Invitrogen). The following
primers were used in real time PCR reactions to determine relative
gene expression:
p21: 5′-TGAGGAGGAGCATGAATGGAGACA-3′ and
5′-AACAGGTCGGACATCACCAGGATT-3′,
Pai-1: 5′-GCTGCACCCTTTGAGAAAGA-3′ and
5′-GCCAGGGTTGCACTAAACAT-3′,
Pai-2: 5′-GGGCTTTATCCTTTCCGTGT-3′ and
5′-GTGTGTCTTTGCTGATCCAC-3′,
Puma: 5′-CCTGGAGGGTCATGTACAATCT-3′ and
5′-TGCTACATGGTGCAGAAAAAGT-3′,
Noxa: 5′-CCACCTGAGTTCGCAGCTCAA-3′ and
5′-GTTGAGCACACTCGTCCTTCAA-3′,
p16: 5′-ATCTGGAGCAGCATGGAGTC-3′ and
5′-TCGAATCTGCACCGTAGTTG-3′,
GAPDH: 5′-TGGCAAAGTGGAGATTGTTGCC-3′ and
5′-AAGATGGTGATGGGCTTCCCG-3′.
Histology
Skin tissue was ﬁxed in 10% formalin overnight. Skin sections
(5 μm) were stained with hematoxylin and eosin (H&E), anti-
cytokeratin 15 (K15) antibody from Neomarkers (Freemont, CA), or
anti-Lhx2 from Santa Cruz (sc-19342) as performed by the UMMS
DERC Morphology Core. TUNEL staining of tissue sections to detect
apoptotic cells was performed using the In Situ Cell Death Detection
Kit, POD (Roche, 11684817910).
SA-β-Galactosidase staining
Fresh skin tissue was washed twice with PBS, followed by brieﬂy
ﬁxing in 2% formaldehyde/0.2% glutaraldehyde for 5 minutes. The
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staining solution [all diluted in 40 mM citrate/sodium phosphate buffer
(pH 6): 5 mM potassium ferricyanide; 5 mM potassium ferrocyanide;
2 mM MgCl2; 150 mM NaCl; 1 mg/ml X-gal] for 4 hours in the dark at
37 °C. After twowashes with PBS, the tissue was ﬁxed overnight in 10%
formalin and parafﬁn embedded. Sections were counterstained with
either H&E or Nuclear Fast Red.
Isolation of bulge stem cells
Epidermal bulge stem cells were isolated according to a previous
protocol (Nowak and Fuchs, 2009). Whole skin was treated with
0.25% trypsin overnight, which allowed complete segregation of the
epidermis from the dermis. The resulting epidermal cell suspensions
were washed with media, resuspended in staining buffer (2% fetal
bovine serum in sterile PBS) and stained with the following
antibodies: phycoerythrin-conjugated rat anti-human CD49f [integrin
α6 chain] (clone GoH3) from BD Pharmingen; biotin-conjugated rat
anti-mouse CD34 (clone RAM34) from eBioscience; strepavidin–
allophycocyanin conjugate from BD Pharmingen. Cells were stained
with 7-aminoactinomycin D (7-AAD, Cat. No. 00-6993-50) from
eBioscience to determine cell viability. FACS was performed by the
UMASS Medical School Flow Cytometry Core Facility.
Wound healing assay
The wound healing procedure was modiﬁed from a previously
described protocol (Tyner et al., 2002). The dorsal surface of
anesthetized mice (0.023 cc/gram body weight, 1.2% Avertin) was
completely shavedwith an electric razor anddisinfectedwithBetadine
(Cardinal Health) and 75% ethanol. A 3-mm punch biopsy was used to
introduce a single wound on the dorsum of each mouse. The wounds
were imaged each day and the diameter of eachwoundwasmeasured.
Healing was deﬁned as the decrease in wound diameter over time and
was expressed as the percentage of the day 0 wound diameter.
Hair growth assay
The procedure for this assay was modiﬁed from a previously
described protocol (Tyner et al., 2002). A 2-cm2 dorsal section of skin
on age-matched mice was shaved with an electric razor at day 0. A
0.5-cm2 square grid was used to measure hair re-growth, which was
deﬁned as the percentage of the total number of squares that are
covered with over 50% new hair. Measurements were taken every
3–4 days.
Results
To study the role of Mdm2 in regulating p53-mediated effects on
premature aging phenotypes, Mdm2-conditional mice (Mdm2c/c)
(Steinman and Jones, 2002) were mated with transgenic mice bearing
the Cre recombinase gene under the transcriptional control of Keratin
5 promoter sequences (K5-Cre) (Zhou et al., 2002). Since the K5
promoter is active in early postnatal development in epidermal
progenitor cells of the skin and hair follicles, induction of Cre
expression should excise exons 11 and 12 in the conditional Mdm2
allele, resulting in loss of functional Mdm2 in the epidermis (Fig. 1A).
To conﬁrm robust Cre recombinase function in the epidermis of
K5-Cre mice, Rosa26 Flox-Stop-β-Geo reporter (R26R) mice were
crossed with K5-Cre mice and the pattern of reporter gene activity
was examined in these compound heterozygous mice. Expression of
β-galactosidase was detected in the interfollicular epidermis and hair
follicles of 4-week old K5-Cre+, R26Rmice, indicating robust and
widespread Cre mediated excision of ﬂoxed alleles in epidermal cells
(Fig. 1B). To document excision of the ﬂoxed exons in the conditional
Mdm2 mice, genomic DNA was isolated from tissues of Mdm2c/c andMdm2c/c, K5-Cre+mice (Mdm2Δ/Δ), and PCR was performed to
determine the status of the Mdm2 alleles. PCR primers to the
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) gene were
used as a positive control. Loss of functional Mdm2 alleles was
observed in the skin of Mdm2Δ/Δ mice, but not in various control
tissues, including spleen (Fig. 1C), liver, lung, kidney or small bowel
(data not shown). To conﬁrm that Cre-excision of the ﬂoxed Mdm2
exons in the epidermis resulted in loss of Mdm2 function, we
examined p53 levels in the epidermis of Mdm2Δ/Δmice at 5 months of
age. Western blot analysis revealed that endogenous p53 protein
levels are slightly increased (3–4 fold by densitometry) in the skin of
Mdm2Δ/Δ mice (Fig. 1D).
Loss of Mdm2 function has been associated with an increase in
p53-mediated cell growth arrest or apoptosis in a number of mouse
models, resulting in aberrant tissue function (Jones et al., 1995;
Montes de Oca Luna et al., 1995; Itahana et al., 2007; Mendrysa et al.,
2006; Lengner et al., 2006; Xiong et al., 2006; Grier et al., 2006).
Surprisingly, Mdm2Δ/Δmice younger than 10 months display no overt
phenotype, despite the loss of Mdm2 function and increased p53
stabilization in the epidermis (Fig. 2A and B). However, all Mdm2Δ/Δ
mice displayed progressive hair loss and decreased skin elasticity as
they continued to age (Fig. 2C). Analysis of hematoxylin & eosin
(H&E)-stained sections of skin from older (14–15 month old)Mdm2Δ/Δ
mice revealed there are fewer hair follicles per millimeter (ﬂ/mm) of
dorsal skin inMdm2Δ/Δmice (0.70 ﬂ/mm) than in controlMdm2c/cmice
(1.4 ﬂ/mm) (p=0.003). In addition, 27.1% of Mdm2Δ/Δ mouse follicles
display an abnormal phenotype compared to 7.0% of the follicles in age-
matched Mdm2c/c controls (p=0.004). These abnormal Mdm2Δ/Δ
follicles were dilated, debris-laden, devoid of a hair shaft, cellularly
atrophic, and morphologically disorganized (Fig. 2D).
In addition to defects in fur maintenance, approximately 10%
of all Mdm2Δ/Δ mice developed severe open skin wounds between
18–24 months of age. As these affected mice were housed individu-
ally, the skin lesions were likely caused by self-grooming. Similar
wounding was not observed in age-matched, Mdm2c/c control mice or
in older K5-Cre transgenic mice. To further examine the epidermal
defects in these mice, skin biopsies were taken from Mdm2Δ/Δ mice
and Mdm2c/c control mice at 16 months of age. There was an obvious
decrease in the thickness of the interfollicular epidermis in older
Mdm2Δ/Δ mouse relative to age-matched controls, accounting for the
diminished integrity of the epidermal layer in older Mdm2Δ/Δ mice
(Fig. 2E). These phenotypes are not present in young Mdm2Δ/Δ mice
(Fig. 2A and B), suggesting a gradual degeneration of epidermal skin
and hair follicle morphology in Mdm2Δ/Δ mice over time.
To examine epidermal p53 levels in older mice, we performed
western blot analysis using skin protein lysates isolated from 20–
23 month old Mdm2Δ/Δ and Mdm2c/c mice, as well as lysates isolated
from γ–irradiated (3 Gy) control mice (Fig. 3A). The amount of p53
present in older Mdm2Δ/Δ skin was far greater than the level of p53
detected in age-matched control Mdm2c/c skin andwas comparable to
p53 levels observed in irradiated Mdm2c/c controls. To determine if
the highly elevated p53 levels in older Mdm2Δ/Δmice correlated with
increased p53 activity, we examined the expression levels of select
p53 target genes in the skin of 5-month old mice and 16-month old
mice (Fig. 3B). Little or no elevation of the expression levels of p53
target genes was observed in the younger mouse skin (left panel). In
contrast, the large increase in p53 protein levels in the older mouse
skin correlated with an increase in p53 target gene activation (right
panel). However, only a subset of p53 target genes displayed
increased expression in older Mdm2Δ/Δ skin samples. Interestingly,
these upregulated p53 targets included genes associated with cell
cycle arrest and senescence (p21, Pai-1 and Pai-2) but not apoptosis
(Puma and Noxa).
To conﬁrm that ablation of Mdm2 and upregulation of p53 activity
in the skin of Mdm2Δ/Δ mice did not induce apoptosis in this tissue,
we performed terminal deoxynucleotidyl transferase dUTP nick end
Fig. 1. Deletion of Mdm2 in epidermis upregulates p53 protein levels. (A) Exons 11 and 12 of the conditional Mdm2 allele (c) are ﬂanked by loxP sites (top). Cre recombinase deletes
these ﬂoxed exons, generating an Mdm2-null allele (Δ, bottom). Green arrows represent PCR primers used to identify the conditional Mdm2 allele and red arrows represent PCR
primers used to detect genomic rearrangement. (B) LacZ staining in Rosa26 Flox-Stop-β-Geo reporter mice expressing the K5-Cre transgene. Scale bar, 100 μm. (C) PCR on genomic
DNA indicates excision of the Mdm2 allele speciﬁcally in the skin of Mdm2c/c mice that also inherited the K5-Cre transgene. Primers to Gapdhwere used as a positive control for the
PCR reactions. (D) Western blot of p53 protein levels in skin from 5-month-old mice. α-Tubulin was used as a loading control for the western.
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Mdm2Δ/Δ and Mdm2c/c mice. TUNEL staining was readily detected
at the base of those follicles undergoing remodeling (catagen-phase)
in bothMdm2Δ/Δ andMdm2c/c tissues (data not shown). This staining
was anticipated because normal fur remodeling is ongoing even in
older mice and appears to be regulated primarily by Bcl2 and not by
p53 (Stenn and Paus, 2001). However, TUNEL positive cells were not
observed in either the follicular or interfollicular epidermis of
older Mdm2c/c or Mdm2Δ/Δ mice (Fig. 3C) or in younger Mdm2c/c or
Mdm2Δ/Δ mice (data not shown), indicating that increased p53
activity in the skin of Mdm2Δ/Δ mice did not correlate with an
increased number of apoptotic cells. These negative results correlate
with the lack of increased apoptotic gene expression seen in the skin
of Mdm2Δ/Δ mice, conﬁrming that the loss of fur and thinning of
the epidermis seen in the Mdm2Δ/Δmice is unlikely to be due to p53-
mediated apoptosis in the skin.
Increased cellular senescence has been linked to aging phenotypes
in other mousemodels (Rodier et al., 2007). Since upregulation of p53
activity in Mdm2Δ/Δ mice resulted in the activation of p53 target
genes primarily involved in cell senescence, we examined the
epidermis of older Mdm2Δ/Δ mice for senescent cells. Skin sections
of 16-month old Mdm2Δ/Δ mice and Mdm2c/c mice were ﬁxed and
stained for senescence-associated β-galactosidase (SA-β-Gal) activity.
SA-β-Gal activity was undetectable in the follicular epithelium of
Mdm2c/c control mice (Fig. 3D, bottom panels), whereas 21% (±3.6%)
of the hair follicles in Mdm2Δ/Δ mice stained positive for SA-β-Gal
activity (Fig. 3D, top panels). Interestingly, SA-β-Gal staining was
particularly acute in the follicular bulge, the region of the follicle
containing the epidermal stem cell compartment (Tumbar et al.,
2004). To conﬁrm senescence of epidermal cells in Mdm2Δ/Δmice, we
examined expression of the p16INK4A tumor suppressor, a gene whose
expression is not governed by p53 and that has been previously
reported to be increased in senescent and aging skin cells of older
mice and humans (Jenkins, 2002; Ressler et al., 2006; Campisi, 2005).A signiﬁcant increase in p16INK4A expression was detected by qPCR in
the skin of older Mdm2Δ/Δ mice, relative to expression levels in age-
matched Mdm2c/c skin (Fig. 3E), conﬁrming that loss of Mdm2–p53
signaling induces an established molecular marker of senescence and
accelerated aging in the epidermis. Assays of age-matched, younger
Mdm2Δ/Δ mice and control Mdm2c/c mice (5–6 months) revealed no
differences in SA-β-Gal staining or in p16INK4A expression in the skin
(data not shown).
SA-β-Gal staining of the follicular bulge region and upregulation of
p16 expression indicates premature cell senescence in the epidermal
stem cell compartment of Mdm2Δ/Δ mice. To conﬁrm that the defect
in Mdm2Δ/Δ mice is due to the reduced numbers of epidermal stem
cells, we examinedMdm2Δ/Δ follicular bulge cells for keratin 15 (K15)
and LIM homeobox protein 2 (Lhx2) staining, speciﬁc markers of
bulge stem cells in mice (Liu et al., 2003; Rhee et al., 2006). Staining of
skin cross sections of older Mdm2Δ/Δ and control Mdm2c/c mice
revealed a decrease in K15-positive (Fig. 4A) and Lhx2-positive
(Fig. 4B) cells in Mdm2Δ/Δ mice. Typical follicles in Mdm2Δ/Δ mice
have very faint K15 and Lhx2 staining (Fig. 4A and B, bottom panels)
compared to age-matched control follicles (Fig. 4A and B, top panels),
and staining is absent in all of the abnormal follicles examined in
Mdm2Δ/Δ mice (data not shown). To conﬁrm a reduction in numbers
of epidermal stem cells inmice ablated for Mdm2, we performed FACS
analysis of epidermal cells harvested from age-matchedMdm2Δ/Δ and
control Mdm2c/c mice and documented the numbers of cells
expressing high levels of both CD34 andα6-integrin, well-established
epidermal stem cells markers (Nowak and Fuchs, 2009). In agreement
with our K15 and Lhx2 staining results, fewer CD34/α6-intgrin
double-positive cells are present in the skin of Mdm2Δ/Δ mice
compared to the numbers of double positive cells in Mdm2c/c control
mice (Fig. 4C and D). Interestingly, while fewer epidermal stem cells
are seen in the skin of Mdm2Δ/Δmice at 3 months and 9 months of age
(before the skin phenotype is observed inmice, Fig. 2A), a much larger
decrease in epidermal stem cell numbers is seen in 14-month old
Fig. 2.Mdm2Δ/Δmice exhibit abnormal hair loss and a thinning of the epidermal layer after 12 months of age. (A) Younger Mdm2c/c (left) andMdm2Δ/Δmice (right) reveals no overt
phenotypic difference. (B) H&E staining of representative hair follicles from young Mdm2c/c (left) and Mdm2Δ/Δ mice (right). Scale bars, 100 μm. (C) Phenotype of older Mdm2Δ/Δ
mice (right) includes increased hair loss in aged mice deleted for Mdm2 compared to older Mdm2c/c (left) mice. (D) H&E staining of representative hair follicles from older Mdm2c/c
(left) and Mdm2Δ/Δ mice (right). Scale bars, 100 μm. (E) H&E staining of interfollicular epidermis from older Mdm2c/c (left) and Mdm2Δ/Δ mice (right). Scale bars, 100 μm.
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Fig. 3. Older Mdm2Δ/Δmice have elevated p53 activity in the skin, leading to increased senescence but not apoptosis. (A) Western blot of p53 protein levels in skin from untreated
and γ-irradiated (3 Gy, 15 hours) 20- to 23-month-old mice. α-Tubulin was used as a loading control. (B) Relative mRNA levels of p53 target genes in untreated skin from young
(left) and older (right) mice determined by qRT–PCR. Values represent the fold difference in Mdm2Δ/Δ mice compared to Mdm2c/c mice (n=3 per genotype). All levels were
normalized to Gapdh expression levels. Standard deviation indicated by error bars. (C) TUNEL staining of skin from an aged Mdm2c/c mouse (left), and Mdm2Δ/Δmouse (right). Scale
bars, 100 μm. (D) Senescence-associated-β-galactosidase activity detected in skin of agedMdm2Δ/Δmice (top) but not in Mdm2c/c mice (bottom). Sections were counterstained with
Nuclear Fast Red. Scale bars, 50 μm. Arrowheads denote β-gal positive stain. (E) Relative p16 mRNA levels in skin from older mice determined by qRT–PCR (n=3 per genotype).
Levels were normalized to Gapdh expression level. Standard deviation indicated by error bars.
6 H.S. Gannon et al. / Developmental Biology 353 (2011) 1–9Mdm2Δ/Δmice (Fig. 4D), when the phenotype of the Mdm2Δ/Δmice is
readily apparent (Fig. 2C).
Loss of tissue regenerative potential and disrupted organ homeo-
stasis are hallmarks of normal aging in mice and are often exacerbated
in mouse models of accelerated aging (Rodier et al., 2007; Campisi,
2005). In skin, follicular bulge stem cells produce transiently
amplifying epidermal progenitor cells that migrate to wounded
areas of the interfollicular epidermis and coordinate the wound
healing response (Tumbar et al., 2004; Taylor et al., 2000). To conﬁrm
that epidermal stem cell function is compromised in older Mdm2Δ/Δ
mice, we compared the decrease in diameter of an introduced 3 mm2
dorsal wound inMdm2Δ/Δmice andMdm2c/c controlmice.Wounds in
younger (2–4 month old) Mdm2Δ/Δ and Mdm2c/c mice healed at a
similar rate (Fig. 5A left panel), with an average 65% wound closure in
mice of both genotypes at 8 days.Wounds in older (14–16 month old)
Mdm2c/c control mice (Fig. 5A right panel) closed at a rate similar to
that seen in the younger mice. In contrast, wounds in the older
Mdm2Δ/Δ mice closed at a much slower rate, consistent with a
decrease in epidermal stem cell function. After 8 days, the wound sites
in control Mdm2c/c mice were fully healed, whereas the wound sites
in age-matchedMdm2Δ/Δmice remainedmostly open (Fig. 5B). These
difference were not due to different rates of epidermal apoptosis at
the site of wounding as no differences in TUNEL staining were
observed in Mdm2Δ/Δ and Mdm2c/c tissue sections (data not shown).
Epidermal stem cells are also required to promote the anagen–
telogen–catagenhair cycle (Tumbar et al., 2004;Morris andPotten, 1999),
and the rate of fur regrowth after shaving of mice is another direct
measure of follicular stem cell function. To further conﬁrm loss ofepidermal stem cell-mediated functions in older Mdm2Δ/Δ mice,
we shaved the fur from a 4 cm2 dorsal area on Mdm2Δ/Δ mice and
Mdm2c/c control mice and measured fur re-growth over time (Fig. 5C).
While there isnodifference in thegrowthof fur inyoungerMdm2Δ/Δmice
and Mdm2c/c mice (data not shown), fur growth in older (14–16 month
old) Mdm2Δ/Δmice is signiﬁcantly delayed relative to control mice in the
3-week interval after shaving (Fig. 5C). In addition, older Mdm2Δ/Δmice
display reduced fur growth even 80 days post-shaving (Fig. 5D).
Discussion
The Mdm2Δ/Δ mice present a premature aging phenotype in the
epidermis that is highly similar to the accelerated aging phenotype
that we observed previously in the skin of p53 m-allele mice,
including a thinning of the epidermal layer, reduced wound healing,
and a reduced capacity to re-grow fur. As deletion of Mdm2 results in
an increase in endogenous p53 levels and upregulation of select p53
target gene expression in the epidermis of Mdm2Δ/Δmice, our results
corroborate that an increase in p53 activity in p53 m-allele mice is
responsible for the accelerated aging phenotypes observed previously
in this model and in certain other p53 models (Tyner et al., 2002;
Maier et al., 2004). However, not all mouse models bearing increased
levels of p53 display premature aging, and retention of some degree of
Mdm2-p53 signaling in these models may well account for the lack of
accelerated aging-like phenotypes in these mice (Garcia-Cao et al.,
2002; Mendrysa et al., 2006).
It is interesting to note that ablation of Mdm2 and upregulation of
p53 in the epidermis did not result in p53 activation of pro-apoptotic
Fig. 4. Hair follicle stem cell markers are diminished in older Mdm2Δ/Δ mice. (A) Follicular keratin 15 staining in older Mdm2c/c (top) and Mdm2Δ/Δ (bottom) mice. Arrowheads
denote speciﬁc staining. Scale bars, 25 μm. (B) Follicular Lhx2 staining in older Mdm2c/c (top) and Mdm2Δ/Δ (bottom) mice. Arrowheads denote speciﬁc staining. Scale bars, 25 μm.
(C) Representative FACS plots for 9-month-old Mdm2c/c (left) and Mdm2Δ/Δ (right) mice. Bulge stem cells (CD34high/α6-Integrinhigh) are shown in black boxes. (D) Summary of the
total percentage of CD34high/α6-Integrinhigh cells determined by FACS analysis in Mdm2c/c (gray bars) andMdm2Δ/Δ (white bars) mice at different ages (n=3 per genotype for each
age group). Standard deviation indicated by error bars.
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et al., 2006; Xiong et al., 2006;Martins et al., 2006). Instead, disruption
of Mdm2–p53 signaling induced SA-β-Gal staining of the follicular
bulge region and upregulation of p16 expression, indicating cellular
senescence within the epidermal stem cell compartment in Mdm2Δ/Δ
mice. Thus, the ability of Mdm2 to properly regulate p53-mediated
senescence in this tissue determines the presence or absence of p53-
associated aging phenotypes. Activation of p53-mediated cell senes-
cence in epidermal stem cells and altered wound healing have also
been observed in mice bearing shortened telomeres (Flores and
Blasco, 2009), supporting a role for p53 activation in regulating
epidermal stem cell function. However, as fur loss and reduced skin
integrity was not reported in these mice, the differences in the level
of p53 activation or the timing of p53-induced senescence in the
epidermis may also underlie the presence or absence of aging-like
phenotypes in the skin.
The results of our study reveal that loss of Mdm2, the concomitant
upregulation of p53, and the subsequent induction of p53-mediated
senescence induces an accelerated aging (but not progeria-like)phenotype in the skin. Although increased p53 levels can be detected
in the skin of younger Mdm2Δ/Δ mice (Fig. 1D), these mice do not
display upregulated levels of p53-target genes in their skin (Fig. 2B),
and the Mdm2Δ/Δ mice appear unaffected up to 10 months (Fig. 2A
and B). However, after 10 months of age fur loss and epidermal
thinning becomes readily apparent in these mice. As stem cells in the
epidermal bulge region are generated during late embryogenesis in
the mouse (Stenn and Paus, 2001), the postnatal ablation of Mdm2
induced by the K5-Cre in ourmodelmay be governing epidermal stem
cell renewal and not the functional differentiation of pre-existing
epidermal stem cells. In keeping with this possibility, it has been
established previously that follicle bulge cells are slow cycling, with
an average of 14 months in the mouse (Morris and Potten, 1999).
Thus, the pre-established epidermal stem cell compartment in
Mdm2Δ/Δ mice likely retain cells that are still capable of differenti-
ating into committed progenitor cells that form the follicular and
inter-follicular epidermis but have lost the capacity to self-renew the
epidermal stem cell compartment, leading to exhaustion of the stem
cell population with age. The precise role of p53-induced senescence
Fig. 5. Bulge stem cell function is impaired in older Mdm2Δ/Δ mice. (A) Wound healing assay of 2- to 4-month old (left) and 14- to 16-month old (right) Mdm2c/c (gray bars) and
Mdm2Δ/Δ mice (white bars). The decrease in diameter of a dorsal punch biopsy wound was measured over time (n=3 per genotype). Standard deviation indicated by error bars.
(B) H&E staining of wounds from aMdm2c/c mouse (left) and a Mdm2Δ/Δmouse (right) at day 8 of the wound healing assay. Scale bars, 250 μm. (C) Hair growth in 16- to 20-month-
old mice. The percentage hair growth for Mdm2c/c mice (solid line) and Mdm2Δ/Δ mice (dotted line) was plotted over time (n=3 per genotype). Standard deviation indicated by
error bars. (F) Pictures of an aged Mdm2c/c mouse (top) and Mdm2Δ/Δ mouse (bottom) at day 1 and day 80 post-shaving.
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further investigation.
Conclusions
Our ﬁndings reveal that activation of p53 due to loss of Mdm2 in
the skin of Mdm2-conditional mice induces p53-mediated senescence
within the epidermal stem cell compartment and a reduction in
epithelial stem cell numbers and functions in older mice. In addition,
Mdm2-mediated inhibition of p53 activity in epithelial cells of the
skin is essential for maintenance of skin integrity and fur as mice age.
Thus, Mdm2–p53 signaling governs certain rapid-aging phenotypes in
skin. The ability of Mdm2 to properly downregulate p53 in other p53
mouse models may therefore account for the presence or absence of
aging-like phenotypes in these models.
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